Connect Biopharma Holdings LTD 20-F annual reports
The annual report filed by foreign private issuers listed on a US exchange — the 10-K’s equivalent for non-US companies.
NASDAQ
Connect Biopharma files its annual report on Form 20-F, detailing changes to its non-employee director compensation program and providing a comprehensive overview of its financial performance and operations.